Recent studies highlight the effectiveness of lenvatinib and pembrolizumab in improving overall survival for patients with ...

Novel small molecule inhibitors show promising efficacy in endometrial cancer, with ongoing trials expanding treatment ...

FDA removes black box warnings for most MHT products, reflecting evidence that breast cancer risk varies by formulation, ...

If you’re a woman of a certain age, your social media feed may be filled with claims that a single therapy will fight ...

A farm in the central Japan prefecture of Nagano is working to save a Japanese horse breed called "Kiso uma," or Kiso horse, with only about 140 such horses remaining in the country. The Kiso horse br ...

Menopause hormone therapy has evolved through decades of research, offering relief from symptoms like hot flashes, sleep ...

Struggling with distressing menopause symptoms? So many of us are. In a 2023 survey, 81 percent of menopausal and ...

"Menopause hormone therapy is widely used to manage menopausal symptoms, yet its impact on memory, cognition, and dementia ...

Oral anticoagulant users have a higher incidence of abnormal uterine bleeding than nonusers, with women under 50 experiencing ...

Electronic data capture (EDC) extract from the ongoing ACR-368 registrational-intent Phase 2b monotherapy trial in OncoSignature-positive (BM+) subjects with endometrial cancer (EC) showed 39% overall ...

AstraZeneca is relying on several upcoming products to help hit its target of $80 billion in revenue by 2030, including drugs ...

The NEO-CYT study, sponsored by Fondazione Melanoma Onlus, will be evaluating MDNA11 in front-line therapy for resectable ...